- Home
- MPWR vs ALC Comparison
MPWR vs ALC Comparison
Compare MPWR & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPWR
- ALC
- Stock Information
- Founded
- MPWR 1997
- ALC 1945
- Country
- MPWR United States
- ALC Switzerland
- Employees
- MPWR N/A
- ALC N/A
- Industry
- MPWR Semiconductors
- ALC Ophthalmic Goods
- Sector
- MPWR Technology
- ALC Health Care
- Exchange
- MPWR Nasdaq
- ALC Nasdaq
- Market Cap
- MPWR 38.6B
- ALC 40.2B
- IPO Year
- MPWR 2004
- ALC N/A
- Fundamental
- Price
- MPWR $840.38
- ALC $79.64
- Analyst Decision
- MPWR Strong Buy
- ALC Buy
- Analyst Count
- MPWR 13
- ALC 11
- Target Price
- MPWR $855.31
- ALC $96.73
- AVG Volume (30 Days)
- MPWR 499.6K
- ALC 2.6M
- Earning Date
- MPWR 10-29-2025
- ALC 11-11-2025
- Dividend Yield
- MPWR 0.74%
- ALC 0.27%
- EPS Growth
- MPWR 358.16
- ALC N/A
- EPS
- MPWR 38.48
- ALC 2.16
- Revenue
- MPWR $2,543,912,000.00
- ALC $10,025,000,000.00
- Revenue This Year
- MPWR $27.04
- ALC $6.21
- Revenue Next Year
- MPWR $15.41
- ALC $7.51
- P/E Ratio
- MPWR $21.84
- ALC $36.17
- Revenue Growth
- MPWR 34.30
- ALC 4.04
- 52 Week Low
- MPWR $438.86
- ALC $77.44
- 52 Week High
- MPWR $954.00
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- MPWR 53.43
- ALC 42.47
- Support Level
- MPWR $800.97
- ALC $77.44
- Resistance Level
- MPWR $869.70
- ALC $80.91
- Average True Range (ATR)
- MPWR 25.00
- ALC 1.31
- MACD
- MPWR -3.39
- ALC 0.01
- Stochastic Oscillator
- MPWR 50.18
- ALC 41.28
About MPWR Monolithic Power Systems Inc.
Monolithic Power Systems is an analog and mixed-signal chipmaker specializing in power management solutions. Its mission is to reduce total energy consumption in end systems. It serves the computing, automotive, industrial, communications, and consumer end markets. MPS uses a fabless manufacturing model, partnering with third-party chip foundries to host its proprietary BCD process technology.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.